Specify a stock or a cryptocurrency in the search bar to get a summary
Piramal Pharma Limited
PPLPHARMAPiramal Pharma Limited operates as a pharmaceutical company in North America, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the spectrum of the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; complex hospital generics business which offers inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain and anesthesia drugs, and other generic and specialty products; and India consumer healthcare business comprising analgesics, skin care, vitamin/mineral supplement, kids' wellness, digestives, women's health, and hygiene and protection. The company was incorporated in 2020 and is based in Mumbai, India. Address: Piramal Ananta, Mumbai, India, 400 070
Analytics
WallStreet Target Price
–P/E ratio
704.875Dividend Yield
0.04 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures PPLPHARMA
Dividend Analytics PPLPHARMA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PPLPHARMA
Stock Valuation PPLPHARMA
Financials PPLPHARMA
Results | 2019 | Dynamics |